Back to Intelligence

#api-sourcing

(5 articles)
Procurement
High ImpactNov 3, 2026

Pharma API Sourcing: How to Build Resilience Against Geopolitical Risk

Pharmaceutical companies face critical vulnerabilities in Active Pharmaceutical Ingredient (API) sourcing due to geographic concentration in China and India, which account for approximately two-thirds

Contract Pharma#api-sourcing#pharmaceutical-supply-chain#supply-chain-resilience
Trade Policy & Tariffs
High ImpactAug 18, 2026

Trump Drug Tariffs Force Pharma Supply Chain Rethink

The Trump administration's proposed tariffs on pharmaceutical products represent a significant structural shift in how the pharmaceutical industry sources and procures drugs, particularly active pharm

Pharmaceutical Commerce#pharmaceutical-tariffs#trump-trade-policy#drug-supply-chain
Trade Policy & Tariffs
High ImpactJul 26, 2026

Iran Conflict Threatens Global Pharmaceutical Supply Chains

A conflict involving Iran poses significant risk to global pharmaceutical supply chains due to the region's strategic importance in drug manufacturing and trade routes. Iran and neighboring countries

Think Global Health#iran-conflict#pharmaceutical-supply-chain#geopolitical-risk
Trade Policy & Tariffs
CriticalJul 23, 2026

India Tariffs Threaten 50% of US Pharmaceutical Supply

A proposed tariff regime targeting India represents an unprecedented threat to the US pharmaceutical supply chain, with potential consequences affecting approximately half of America's imported medica

Washington Examiner#india-tariffs#pharmaceutical-supply#drug-imports
Trade Policy & Tariffs
High ImpactJul 23, 2026

Trump's 200% Drug Tariffs Set to Reshape Global Pharma Supply Chain

The Trump administration's phased tariff plan on imported generic medications represents a structural shift in pharmaceutical supply chain strategy, with 100% duties beginning August 2028 and escalati

FreightWaves#pharmaceutical-tariffs#drug-supply-chain#reshoring-policy